(February 14, 2019, 1:59 PM EST) -- PHILADELPHIA — A federal district court did not abuse its discretion in ruling that a pharmaceutical company and certain of its senior executives failed to rebut the presumption of reliance in...
Court’s Reliance Ruling In Securities Class Action Was Proper, Investors Argue
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login